Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In this study, we investigated the effects of HLA-DQB1*03:01 on the onset age of type-1 narcolepsy. We pooled data from 5,339 cases from China, Europe, Korea, Japan, and the United States to conduct the first transethnic study on age of onset (OA). GWAS was used to detect the associated genes. HLA alleles were imputed by HIBAG. Three datasets (DGN, CHINA, and CAUC) were used for TCR analyses. Chinese patients were found to have an earlier age of onset. Independently of this, only one strong GWAS significant effect was observed, summarized by the presence of DQB1*03:01 and centered around the coding region of this gene. In contrast, DQ0602 dosage did not strongly affect onset, and other known narcolepsy-associated genetic loci had minor effects. The DQB1*03:01 effect (mean -3.47 years, p=1.7 10-18) showed no heterogeneity across ethnic groups and was independent of common allelic variation at DQA1 in cis of DQB1*03:01 (DQA1*03:03; DQA1*0505; DQA1*06:01). This effect may be explained by presentation of peptide(s) across all DQ0301 heterodimers, or, considering genetic effects mapping on TCRA and TCRB, effects on TCR repertoire. Using bulk and single-cell RNA-seq data across two ethnic groups, we found that DQB1*03:01 alters TCR repertoire at specific positions, most significantly within the CDR2A, CDR2B and CDR3B loops. These results illustrate the remarkable conservation of narcolepsy genetic effects across ethnicity and suggest that specific TCRs regulate narcolepsy onset. This result will likely be illuminating of the pathophysiology once T cells causative of the disease have been identified.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204273PMC
http://dx.doi.org/10.1101/2025.06.14.25328971DOI Listing

Publication Analysis

Top Keywords

age onset
12
ethnic groups
8
genetic effects
8
tcr repertoire
8
onset
6
effects
5
hla-dqb1*0301 age
4
onset type
4
narcolepsy
4
type narcolepsy
4

Similar Publications

Importance: It is unclear whether the duration of amyloid-β (Aβ) pathology is associated with neurodegeneration and whether this depends on the presence of tau.

Objective: To examine the association of longitudinal atrophy with Aβ positron emission tomography (PET)-positivity (Aβ+) and the estimated duration of Aβ+ (Aβ+ duration), controlling for tau-positivity.

Design, Setting, And Participants: Data for this longitudinal cohort study were drawn from the Wisconsin Registry for Alzheimer Prevention and the Wisconsin Alzheimer Disease Research Center Clinical Core Study.

View Article and Find Full Text PDF

Objectives: Patients diagnosed with amyotrophic lateral sclerosis (ALS) typically describe symptoms of fatigue. Despite this frequency, the underlying mechanisms of fatigue are poorly understood, and are likely multifactorial. To help clarify mechanisms, the present systematic review was undertaken to determine the risk factors related to fatigue in ALS.

View Article and Find Full Text PDF

The COVID-19 pandemic significantly worsened mental health (MH) challenges among young people. We aimed to assess changes in mental health-related outpatient care before and after the onset of the pandemic. In this nationwide cross-sectional study, we retrieved visits to general practitioners (GP) resulting in the coding of a MH disorder and/or the prescribing of any psychotropic medication for children aged 6 to 17 years, from January 1, 2016 to May 31, 2022 in France.

View Article and Find Full Text PDF

To identify clinical and demographic predictors associated with the timing of transition from psoriasis (PsO) to psoriatic arthritis (PsA), and to compare the characteristics of patients with concurrent PsO-PsA onset versus those with prolonged transition. A multi-center, observational study was conducted using data from the Turkish League Against Rheumatism (TLAR) network including PsA patients fulfilling CASPAR criteria. Patients were categorized into two groups: Group 1 (concurrent PsO and PsA onset within ± 1 year) and Group 2 (prolonged transition to PsA, > 1 year after PsO).

View Article and Find Full Text PDF

Objectives: Recommendations regarding the use of third-trimester ultrasound lack universal consensus. Yet, there is evidence which supports its value in assessing fetal growth, fetal well-being, and a number of pregnancy-related complications. This literature review evaluates the available scientific evidence regarding its applications, usefulness, and the timing of the third-trimester scan in a low-risk population.

View Article and Find Full Text PDF